Russell B Richerson

Title: Innovations by Russell B Richerson: A Glimpse Into His Patented Contributions

Introduction

Russell B Richerson, an accomplished inventor based in Lake Zurich, IL, has made significant strides in the field of immunoassay technology. With two patents to his name, Richerson’s work contributes to advancements in medical diagnostic tools that enhance the detection of antibodies and analytes in patient samples.

Latest Patents

Richerson's latest inventions showcase his expertise and dedication to improving medical diagnostics. His first notable patent is the "Chemiluminescent immunoassay for antibody detection." This invention utilizes a precomplex reagent that comprises an enhancer compound, such as a hapten, and a conjugate featuring a chemiluminescent signal-generating compound. Kits designed for executing this chemiluminescent assay are also provided, representing a significant innovation in the detection of antibodies.

The second patent, titled "Self-performing immunochromatographic device," presents improved chromatographic strip binding assay devices capable of determining the presence or amount of an analyte in a patient sample. This device employs assay label reagents that interact with capture reagents immobilized in a designated testing region of the strip substrate, generating a visually detectable image that indicates the test result. The elegant design of the test result images, which are represented by a minus sign (-) for negative results and a plus sign (+) for positive results, ensures users—both skilled and untrained—can interpret the results without confusion.

Career Highlights

Russell B Richerson is affiliated with Abbott Laboratories Corporation, a leader in the field of health care and diagnostics. His contributions through patents not only underscore his innovative spirit but also highlight the importance of collaboration and research in the quest to develop more effective medical diagnostic solutions.

Collaborations

Richerson has worked alongside esteemed colleagues, such as Eugene W Osikowicz and Michael J Beggs, in the endeavor to develop and refine these patent technologies. Their collective expertise undoubtedly enhances the impact of their innovations on the medical community.

Conclusion

In summary, Russell B Richerson’s contributions to the field of immunoassay technology through his patents reflect a commitment to innovation and improvement in medical diagnostics. With the backing of Abbott Laboratories Corporation and a collaborative team, Richerson continues to pave the way for advancements that enhance healthcare outcomes.